Übersichtsarbeiten - OUP 11/2012

Behandlungsalgorithmen der chronischen Osteomyelitis

22. Frommelt L: Prinzipien der Antibiotikabehandlung bei periprothetischen Infektionen. Der Orthopäde 2004; 33: 822–8. CrossRef MEDLINE

23. Schmelz A, Kinzl L, Einsiedel T: Osteitis. Infektionen des Bewegungsapparates. Unfallchirurg 2007; 110: 1039–58. MEDLINE

24. Rao N, Ziran BH, Lipsky BA: Treating osteomyelitis: antibiotics and surgery. Plast Reconstr Sur. 2011; 127 Suppl 1: 177S–87S. CrossRef MEDLINE

25. Lew DP, Waldvogel FA: Osteomyelitis. Lancet 2004; 364: 369–79. CrossRef MEDLINE

e1. Cierny 3rd G, Mader JT, Penninck JJ: The Classic: A clinical staging system for adult osteomyelitis. Clinical Orthopaedics and Related Research 2003; 414: 7. MEDLINE

e2. Zimmerli W, Fluckiger U: Verlaufsformen und Mikrobiologie der bakteriellen Osteomyelitis. Orthopäde 2004; 33: 267–72. MEDLINE

e3. Kutscha-Lissberg F, Hebler U, Kalicke T, et al.: Prinzipien chirurgischer Therapiekonzepte der postoperativen und chronischen Osteomyelitis. Orthopäde 2004; 33: 439–54. MEDLINE

e4. Miller MB, Bassler BL: Quorum sensing in bacteria. Annu Rev Microbiol 2001; 55: 165–99. MEDLINE

e5. Rumbaugh KP, Diggle SP, Watters CM, et al.: Quorum sensing and the social evolution of bacterial virulence. Current Biology 2009; 19: 341–5. MEDLINE

e6. Costerton JW: Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 2005; 437: 7–11. MEDLINE

e7. Anderson GG, O’Toole GA: Innate and induced resistance mechanisms of bacterial biofilms. Bacterial Biofilms 2008: 85–105. MEDLINE

e8. Bjarnsholt T: Introduction to Biofilms. Biofilm Infections 2010: 1–9.

e9. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318. CrossRef MEDLINE

e10. Donlan RM: Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 2001; 33: 1387–92. CrossRef MEDLINE

e11. Monds RD, O’Toole GA: The developmental model of microbial biofilms: ten years of a paradigm up for review. Trends in Microbiology 2009; 17: 73–87. CrossRef MEDLINE

e12. Schnettler R, Steinau HU: Septic bone and joint surgery. Thieme Medical Pub 2010.

e13. Lewis K: Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5: 48–56. CrossRef MEDLINE

e14. Sendi P, Proctor RA: Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends in Microbiology 2009; 17: 54–8. CrossRef MEDLINE

e15. Wagner F: Laboruntersuchungen zur Osteitisdiagnostik. Trauma und Berufskrankheit 2009; 11: 184–6. CrossRef

e16. Ledermann HP, Kaim A, Bongartz G, et al.: Pitfalls and limitations of magnetic resonance imaging in chronic posttraumatic osteomyelitis. European Radiology 2000; 10: 1815–23. MEDLINE

e17. Azzam K, McHale K, Austin M, et al.: Outcome of a second two-stage reimplantation for periprosthetic knee infection. Clinical Orthopaedics and Related Research 2009; 467: 1706–14. MEDLINE PubMed Central

e18. Simpson AHRW, Deakin M, Latham JM: Chronic osteomyelitis: The Effect of the Extent of Surgical Resection on Infection-Free Survival. J Bone Joint Surg Br 2001; 83: 403–7. MEDLINE

e19. Heppert V, Wagner C, Glatzel U, et al.: Prinzipien der operativchirurgischen Therapie der Osteitis. Trauma und Berufskrankheit 2002; 4: 321–8.

e20. Tiemann AH, Hofmann GO: Principles of the therapy of bone infections in adult extremities : Are there any new developments? Strategies Trauma Limb Reconstr 2009; 4: 57–64. MEDLINE

e21. Luther C, Unger K, Heppert V, et al.: Chronische Osteitis der unteren Extremitat. Interdisziplinäre Behandlungskonzepte. Unfallchirurg 2009; 113: 386–93. MEDLINE

e22. Tu YK, Yen CY: Role of vascularized bone grafts in lower extremity osteomyelitis. Orthop Clin North Am 2007; 38: 37–49. CrossRef MEDLINE

e23. Gerlach UJ, Seide K, Weinrich N, et al.: Segmenttransport. Trauma und Berufskrankheit 2007; 9: 117–21.

e24. Kocaoglu M, Eralp L: Reconstruction of segmental bone defects due to chronic osteomyelitis with use of an external fixator and an intramedullary nail. The Journal of Bone and Joint Surgery 2006; 88: 2137. CrossRef MEDLINE

e25. Schmidmaier G, Capanna R, Wildemann B, et al.: Bone morphogenetic proteins in critical-size bone defects: what are the options? Injury 2009; 40: 39–43. MEDLINE

e26. Grimme C, Schoop R, Gerlach UJ: Biologischer Defektaufbau. Trauma und Berufskrankheit 2010; 12: 42–50.

e27. Tiemann AH, Homagk L, Diefenbeck M, et al.: Hüftprothesenerhalt mit lokaler chirurgischer Revision und Anlage einer Fistula persistens. Der Unfallchirurg 2007; 110: 1021–9. CrossRef MEDLINE

e28. Landersdorfer CB, Bulitta JB, Kinzig M, et al.: Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet 2009; 48: 89–124. MEDLINE

e29. Perlroth J, Kuo M, Tan J, et al.: Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008; 168: 805–19. MEDLINE

e30. Euba G, Murillo O, Fernandez-Sabe N, et al.: Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob Agents Chemother 2009; 53: 2672–6. MEDLINE PubMed Central

e31. Kampe KK, Sobottka I, Kluge S: Patienten mit Problemkeimen. Intensivmedizin up2date 2010; 6: 181–201.

e32. Calhoun JH, Manring MM: Adult osteomyelitis. Infect Dis Clin North Am 2005; 19: 765–86. MEDLINE

SEITE: 1 | 2 | 3 | 4 | 5 | 6